Abstract
We tested the validity of the beta-Neocept test for early pregnancy against that of the plasma human chorionic gonadotropin beta-subunit radioimmunoassay (beta-HCG RIA). The beta-Neocept test had a sensitivity of 88%, a specificity of 93%, a positive predictive value of 95%, a negative predictive value of 84% and an accuracy of 90%. In view of these performance characteristics, its low cost and its ease of use, the beta-Neocept test could be used as the initial pregnancy test when there is a high probability of pregnancy, as there was in this study population, which consisted of 111 women attending endocrine infertility clinics. The more expensive beta-HCG RIA could be reserved for special indications and for patients in whom the results of the urinary hemagglutination inhibition tests are inconsistent with the clinical signs and symptoms.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ho Yuen B., Cannon W., Lewis J., Sy L., Woolley S. A possible role for prolactin in the control of human chorionic gonadotropin and estrogen secretion by the fetoplacental unit. Am J Obstet Gynecol. 1980 Feb 1;136(3):286–291. doi: 10.1016/0002-9378(80)90852-2. [DOI] [PubMed] [Google Scholar]
- McCready J., Braunstein G. D., Helm D., Wade M. E. Modification of the choriogonadotropin beta-subunit radioimmunoassay for determination of urinary choriogonadotropin. Clin Chem. 1978 Nov;24(11):1958–1961. [PubMed] [Google Scholar]